PICC Lines Do Not Require Routine Heparin Lock
For PICCs in active use (daily access), saline flush is appropriate and heparin offers no proven benefit over saline for maintaining patency. For PICCs accessed intermittently (not daily), low-concentration heparin (5-10 U/mL) flushed 1-2 times weekly can be considered to maintain patency 1.
Active Use PICCs (Daily Access)
Routine saline flushing is the standard of care for PICCs being used regularly 1. Multiple guidelines explicitly state that heparin flush provides no additional benefit over saline when catheters are accessed daily or continuously 2, 1.
- Flush with normal saline after each infusion or blood sampling 3
- No heparin needed when the catheter is closed for less than 8 hours 1
- Most hospital PN and medication infusions occur continuously or with short intervals, making heparinization irrelevant 1
The 2018 ESPGHAN/ESPEN pediatric guidelines specifically state: "Routine use of heparin flush for the prevention of thrombotic occlusion in CVC being used on a daily basis cannot be recommended over use of saline flush due to lack of proven benefit in children" 2. This recommendation extrapolates to adult practice, supported by the 2009 ESPEN guidelines confirming that "intermittent flushing with heparin is no more beneficial than flushing with normal saline alone" 1.
Recent research reinforces this: a 2025 study in blood cancer patients found no significant difference in PICC patency between heparin and saline locking, while heparin was associated with more side effects, higher costs, and increased nursing time 4.
Intermittent Use PICCs (Weekly or Less Frequent Access)
For PICCs accessed infrequently (weekly or less), low-concentration heparin (5-10 U/mL) flushed 1-2 times weekly may help maintain patency 2. The 2015 ESMO oncology guidelines recommend weekly flushes for tunneled cuffed catheters and PICC lines not in active use 3.
- Use 5-10 U/mL heparinized saline (not the concentrated 100 U/mL solutions) 2
- Flush 1-2 times per week when catheter remains unused 2
- Always flush with saline before heparinization 1
Critical Safety Considerations
FDA Warning on Heparin Confusion
Never use therapeutic-strength Heparin Sodium Injection vials as catheter lock flush 5. Fatal hemorrhages have occurred in pediatric patients when 1 mL therapeutic heparin vials (10,000 units/mL) were confused with catheter lock flush vials. The FDA explicitly states: "Do not use Heparin Sodium Injection as a 'catheter lock flush' product" 5.
Heparin Risks
- Heparin-induced thrombocytopenia (HIT) is a serious antibody-mediated reaction that can progress to life-threatening thrombosis 5
- Hemorrhage risk increases, particularly in patients over 60 years 5
- Lipid precipitation can occur when heparin is used with lipid-containing PN; always interpose saline flush 1
Special Populations
Neonates and Pediatrics: The evidence is conflicting. While some data suggest heparin may reduce PICC occlusion in newborns, potential risks remain undefined, and routine use cannot be recommended 2. A 2025 study found no difference in elective removal rates or complications with heparin use in preterm infants 6. A 1999 study confirmed heparin is not required for peripheral IV locks in neonates 7.
Oncology Patients: Routine prophylactic anticoagulation is not recommended for preventing catheter-related thrombosis 3. Saline flushing to prevent fibrin buildup is the standard approach 3.
Practical Algorithm
Step 1: Determine catheter access frequency
- Daily or continuous use → Saline flush only after each use
- Weekly or less frequent → Consider low-dose heparin (5-10 U/mL) 1-2x/week
Step 2: If using heparin for intermittent access
- Flush with saline first
- Then lock with 5-10 U/mL heparinized saline
- Never use concentrated therapeutic heparin vials
Step 3: Special circumstances requiring saline only
- Lipid-containing PN infusions
- Valve-tipped catheters (per manufacturer instructions) 1
- Neonates (insufficient safety data) 2
Step 4: Monitor for complications regardless of flush solution
- Platelet counts (HIT surveillance)
- Catheter patency
- Signs of thrombosis or infection
The evidence overwhelmingly supports that saline is equivalent to heparin for maintaining PICC patency in active use, with heparin offering no mortality or morbidity benefit while introducing unnecessary risks and costs 1, 8, 4.